Life-extending treatment for metastatic breast cancer now licenced in UK after one pr [Archive]

View Full Version : Life-extending treatment for metastatic breast cancer now licenced in UK after one pr

News

07-04-2014, 03:52 AM

From 3 July 2014, Halaven® (eribulin) is licenced in the UK for the treatment of patients with locally advanced or metastatic breast cancer (MBC) who have progressed after at least one...

More... (http://www.medicalnewstoday.com/releases/279185.php)